GRL093-22 is a potent and selective G protein-coupled receptor kinase (GRK) inhibitor, with IC 50 s of 60 and 40 nM for GRK5 and GRK6 , respectively. GRL093-22 has the potential for the research of heart failure and multiple myeloma.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > G Protein-coupled Receptor Kinase (GRK)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.